Wellgistics Health Inc's fundamentals are relatively stable, and its growth potential is good.Its valuation is considered fairly valued, ranking 161/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
WGRX's Score
Industry at a Glance
Industry Ranking
161 / 208
Overall Ranking
480 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
WGRX Highlights
StrengthsRisks
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Growing
The company is in a growing phase, with the latest annual income totaling USD 18.13M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 18.13M.
Overvalued
The company’s latest PE is -0.38, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.68M shares, increasing 43.54% quarter-over-quarter.
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
Ticker SymbolWGRX
CompanyWellgistics Health Inc
CEOMr. Brian Norton
Websitehttps://wellgisticshealth.com/
FAQs
What is the current price of WGRX (WGRX)?
The current price of WGRX (WGRX) is 0.486.
What is the symbol of WGRX?
The ticker symbol of WGRX is WGRX.
What is the 52-week high of WGRX?
The 52-week high of WGRX is 7.040.
What is the 52-week low of WGRX?
The 52-week low of WGRX is 0.336.
What is the market capitalization of WGRX?
The market capitalization of WGRX is 43.45M.
What is the net income of WGRX?
The net income of WGRX is -6.86M.
Is WGRX (WGRX) currently rated as Buy, Hold, or Sell?
According to analysts, WGRX (WGRX) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of WGRX (WGRX)?
The Earnings Per Share (EPS TTM) of WGRX (WGRX) is -1.272.